GO:0070668 positive regulation of mast cell proliferation: Signaling Pathways, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070668 describes any process that activates or increases the rate or extent of mast cell proliferation, a key event in allergy, asthma, and tumor immunity.
• Stem cell factor (SCF) and IL-4 are major positive regulators of human intestinal mast cell proliferation and survival.
• Mast cell proliferation is controlled by a network of cytokines, growth factors, and microRNAs, including miR-490-5p in irritable bowel syndrome.
• In cancer, mast cell accumulation can be either pro-tumor or anti-tumor depending on the tumor microenvironment, as shown in esophageal squamous cell carcinoma and melanoma.
• CRISPR-based knockout, knock-in, and overexpression models are essential to dissect causal roles of specific genes in mast cell proliferation.
• Targeting positive regulators of mast cell proliferation, such as ketotifen-modulated pathways, offers therapeutic potential in inflammatory diseases.
Description
Mast cells are tissue-resident immune cells that originate from hematopoietic progenitors and play central roles in allergic reactions, inflammation, and host defense. The process by which these cells increase in number, termed positive regulation of mast cell proliferation (GO:0070668), is critical for understanding how mast cell populations expand under both physiological and pathological conditions. This GO term encompasses any molecular event that activates or increases the rate or extent of mast cell proliferation, including cytokine signaling, growth factor stimulation, and microRNA-mediated regulation. Researchers study this process because dysregulated mast cell proliferation contributes to asthma, irritable bowel syndrome, and tumor progression, making it a target for therapeutic intervention. Recent single-cell transcriptomics has revealed functional heterogeneity among mast cells in tumors, underscoring the need to understand the regulatory mechanisms that control their proliferation. Furthermore, genetic tools such as CRISPR knockout and knock-in models are indispensable for causally linking specific genes to mast cell proliferation.
positive regulation of mast cell proliferation At A Glance
| GO ID | GO:0070668 |
|---|---|
| GO term | positive regulation of mast cell proliferation |
| Ontology | biological_process |
| Synonym | activation of mast cell proliferation; stimulation of mast cell proliferation; up regulation of mast cell proliferation; up-regulation of mast cell proliferation; upregulation of mast cell proliferation |
| Major function | Activates or increases the rate or extent of mast cell proliferation |
| Related processes | Cytokine signaling, growth factor signaling, cell cycle regulation, immune cell expansion |
| Key regulators | SCF, IL-4, miR-490-5p, ketotifen-modulated pathways |
| Disease relevance | Asthma, irritable bowel syndrome, cancer, allergic inflammation |
What Is GO:0070668?
GO:0070668, positive regulation of mast cell proliferation, is defined as any biological process that activates or increases the rate or extent of mast cell proliferation. This includes signaling pathways triggered by cytokines such as stem cell factor (SCF) and IL-4, as well as intracellular cascades that promote cell cycle entry and survival in mast cells. The term is a child of 'regulation of mast cell proliferation' and is distinct from negative regulation, which would decrease proliferation. Synonyms include activation of mast cell proliferation, stimulation of mast cell proliferation, and upregulation of mast cell proliferation.
Why Is positive regulation of mast cell proliferation Important in Cell Biology?
Positive regulation of mast cell proliferation is fundamental to immune responses and tissue remodeling, but when dysregulated it drives chronic inflammatory diseases and can influence tumor progression. Understanding the molecular triggers of mast cell expansion enables the development of targeted therapies for asthma, irritable bowel syndrome, and cancers where mast cells play a role. Moreover, the interplay between mast cells and their microenvironment, as revealed by single-cell transcriptomics, highlights the need to study proliferation in context.
• Mast cell proliferation is a hallmark of allergic inflammation and asthma, where increased mast cell numbers correlate with disease severity.
• In irritable bowel syndrome, mast cell proliferation and activation contribute to visceral hypersensitivity, with miR-490-5p playing a regulatory role.
• Stem cell factor (SCF) and IL-4 are potent positive regulators of human intestinal mast cell proliferation, providing mechanistic insight into gut immunity.
• In esophageal squamous cell carcinoma, mast cells display functional heterogeneity and can exert anti-tumor effects, making their proliferation a subject of active investigation.
• Mouse mast cell tryptase Mcpt6 has a protective role in melanoma, indicating that mast cell products can influence tumor outcomes.
• Ketotifen fumarate modulates the gingival microenvironment, potentially affecting mast cell proliferation in feline gingivitis.
• IL-4/Stat6 signaling regulates novel genes in T lymphocytes, some of which may influence mast cell proliferation indirectly.
• CRISPR screening and knockout models are essential to identify causal genes in mast cell proliferation pathways.
• Understanding positive regulation of mast cell proliferation can guide the development of mast cell-stabilizing drugs.
• Mast cell proliferation is a potential biomarker for disease activity in inflammatory conditions.
What Happens During positive regulation of mast cell proliferation?
Cytokine and Growth Factor Signaling
In simple terms: Molecules like SCF and IL-4 tell mast cells to divide.
Stem cell factor (SCF) and interleukin-4 (IL-4) are key positive regulators of human intestinal mast cell proliferation. SCF binds to the KIT receptor on mast cells, activating signaling cascades that promote survival and proliferation. IL-4 enhances mast cell responses and can synergize with SCF to increase proliferation. These cytokines are produced by stromal cells, T cells, and other immune cells in the tissue microenvironment.
MicroRNA-Mediated Regulation
In simple terms: Small RNA molecules can fine-tune mast cell proliferation.
MicroRNAs such as miR-490-5p have been implicated in mast cell regulation in irritable bowel syndrome. Dysregulated microRNA expression can alter the expression of genes controlling cell cycle and survival, thereby influencing mast cell proliferation. This adds a layer of post-transcriptional control to the process.
Intracellular Signaling Pathways
In simple terms: Inside the cell, specific proteins relay growth signals to the nucleus.
Downstream of cytokine receptors, pathways such as JAK/STAT, PI3K/AKT, and MAPK are activated to drive proliferation. IL-4/Stat6 signaling regulates a set of genes in T lymphocytes, some of which may also operate in mast cells. These pathways converge on cell cycle regulators like cyclins and CDKs to promote progression through the cell cycle.
Interaction with Tumor Microenvironment
In simple terms: In tumors, mast cells can be told to multiply or not depending on signals around them.
Single-cell transcriptomics in esophageal squamous cell carcinoma revealed functional heterogeneity among mast cells, with some subsets exhibiting anti-tumor roles. The proliferation of mast cells in tumors may be influenced by tumor-derived factors, and their accumulation can either promote or inhibit tumor growth. In melanoma, mouse mast cell tryptase Mcpt6 was shown to have a protective role, suggesting that mast cell products can modulate tumor immunity.
Pharmacological Modulation
In simple terms: Drugs can change how fast mast cells multiply.
Ketotifen fumarate, an anti-allergic drug, attenuated feline gingivitis and modulated the gingival microenvironment, potentially affecting mast cell proliferation. This suggests that pharmacological agents can influence positive regulation of mast cell proliferation. Understanding these effects can guide therapeutic strategies for inflammatory diseases.
Key Genes Involved in GO:0070668 positive regulation of mast cell proliferation
The following genes and proteins are experimentally implicated in the positive regulation of mast cell proliferation, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| KIT | Receptor for stem cell factor (SCF); drives mast cell proliferation and survival | Target for mast cell-related diseases; studied via knockout and inhibitors |
| IL4 | Cytokine that enhances mast cell proliferation, especially in synergy with SCF | Key regulator in intestinal mast cells; potential therapeutic target |
| STAT6 | Transcription factor downstream of IL-4 signaling; regulates gene expression | Mediates IL-4-induced gene programs in immune cells |
| MIR490 | MicroRNA miR-490-5p; regulates mast cell function in irritable bowel syndrome | Biomarker and potential therapeutic target in IBS |
| CHMP4C | Involved in necroptosis regulation via RIPK1/RIPK3/MLKL; may affect cell survival | Studied in pancreatic cancer; potential link to mast cell survival |
| MCPT6 | Mouse mast cell tryptase; protective role in melanoma | Model for mast cell-derived proteases in tumor immunity |
| TPSAB1 | Human mast cell tryptase; marker of mast cell activation | Clinical biomarker in allergic diseases |
| CMA1 | Chymase; mast cell-specific protease | Potential role in tissue remodeling and inflammation |
| FCER1A | High-affinity IgE receptor alpha chain; triggers mast cell activation | Central to allergic responses; target for asthma therapy |
| KITLG | Stem cell factor; ligand for KIT | Critical for mast cell development and proliferation |
| JAK3 | Janus kinase involved in cytokine signaling | Potential mediator of IL-4-driven proliferation |
| PIK3CD | PI3K catalytic subunit; downstream of KIT | Involved in survival and proliferation signaling |
| MAPK1 | ERK2; MAP kinase pathway component | Transmits proliferative signals from KIT |
| CCND1 | Cyclin D1; cell cycle regulator | Promotes G1/S transition in proliferating mast cells |
| BCL2L1 | Anti-apoptotic protein; promotes survival | May enhance mast cell survival and proliferation |
| RIPK1 | Kinase involved in necroptosis and survival signaling | Modulated by CHMP4C; potential role in mast cell fate |
| RIPK3 | Kinase that can induce necroptosis | Interacts with RIPK1; may influence mast cell survival |
| MLKL | Executioner of necroptosis | Downstream of RIPK1/RIPK3; potential impact on mast cell proliferation |
How Is positive regulation of mast cell proliferation Regulated?
Positive regulation of mast cell proliferation is controlled by a balance of stimulatory and inhibitory signals. Key positive regulators include stem cell factor (SCF) and IL-4, which activate KIT and IL-4 receptor signaling, respectively. These pathways converge on intracellular kinases such as JAK, PI3K, and MAPK, leading to activation of transcription factors like STAT6 that drive proliferation-associated gene expression. MicroRNAs, such as miR-490-5p, can modulate these pathways post-transcriptionally. Additionally, the tumor microenvironment can influence mast cell proliferation through soluble factors and cell-cell contact, as observed in esophageal squamous cell carcinoma. Pharmacological agents like ketotifen can also modulate mast cell proliferation indirectly by altering the tissue microenvironment.
positive regulation of mast cell proliferation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| KIT | Asthma, allergic inflammation | Knockout mouse, human mast cell lines |
| IL4 | Irritable bowel syndrome, allergy | IL-4 knockout or overexpression in mast cells |
| MIR490 | Irritable bowel syndrome | miR-490-5p mimic/inhibitor in mast cell cultures |
| MCPT6 | Melanoma | Mcpt6 knockout mouse melanoma model |
| CHMP4C | Pancreatic cancer | CRISPR knockout in pancreatic cancer cell lines |
Asthma and Allergic Inflammation
In asthma, increased mast cell numbers in the airways contribute to bronchoconstriction and inflammation. Positive regulation of mast cell proliferation is driven by allergens and cytokines such as SCF and IL-4, leading to mast cell hyperplasia. Targeting these pathways could reduce mast cell burden and alleviate symptoms.
Irritable Bowel Syndrome (IBS)
Mast cell proliferation and activation in the intestinal mucosa are implicated in IBS pathogenesis, with miR-490-5p playing a regulatory role. Increased mast cell numbers correlate with visceral hypersensitivity and abdominal pain. Modulating mast cell proliferation may offer therapeutic benefit in IBS.
Cancer
Mast cells can either promote or inhibit tumor growth depending on the cancer type and microenvironment. In esophageal squamous cell carcinoma, single-cell transcriptomics revealed functional heterogeneity, with some mast cell subsets exhibiting anti-tumor roles. In melanoma, mouse mast cell tryptase Mcpt6 was protective, suggesting that mast cell-derived mediators can influence tumor immunity. Understanding how mast cell proliferation is regulated in tumors is critical for developing immunotherapies.
Gingivitis and Periodontal Disease
Ketotifen fumarate attenuated feline gingivitis and modulated the gingival microenvironment, potentially by affecting mast cell proliferation. Mast cells are present in gingival tissue and can contribute to inflammation. This highlights the broader relevance of mast cell proliferation in oral inflammatory diseases.
From positive regulation of mast cell proliferation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate mast cell proliferation? | CRISPR knockout in human mast cell line (e.g., HMC-1) |
| Does a point mutation in KIT affect proliferation? | Point mutation knock-in via CRISPR in primary mast cells |
| Can overexpression of miR-490-5p alter mast cell numbers? | Lentiviral overexpression in mast cells |
| What is the role of IL-4 in mast cell proliferation in vivo? | IL-4 knockout mouse model |
| How does ketotifen affect mast cell proliferation? | Feline gingivitis model with ketotifen treatment |
| What is the impact of Mcpt6 on melanoma growth? | Mcpt6 knockout mouse melanoma model |
How to Study the positive regulation of mast cell proliferation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry | Mast cell number, proliferation index | Quantifying mast cell expansion in vitro and in vivo |
| Single-cell RNA-seq | Transcriptomic heterogeneity of mast cells | Identifying proliferative subsets in tumors |
| CRISPR knockout screen | Genes affecting mast cell proliferation | Discovery of novel regulators |
| Western blot | Protein expression and signaling activation | Validating pathways in mast cell lines |
| Immunohistochemistry | Tissue mast cell density and localization | Assessing mast cell proliferation in patient samples |
| MicroRNA profiling | Expression of regulatory microRNAs | Linking miR-490-5p to IBS |
| Pharmacological assay | Effect of drugs on mast cell proliferation | Testing ketotifen in gingivitis model |
| Mouse models | In vivo mast cell proliferation and disease outcomes | Studying Mcpt6 in melanoma |
Flow Cytometry
Flow cytometry is used to quantify mast cell numbers and proliferation by staining for surface markers such as KIT and FcεRI, and by using proliferation dyes like CFSE. This method allows researchers to assess the effect of genetic or pharmacological interventions on mast cell proliferation.
Single-Cell Transcriptomics
Single-cell RNA sequencing reveals functional heterogeneity among mast cells and identifies subsets with different proliferative capacities. This technique has been applied to esophageal squamous cell carcinoma to uncover anti-tumor mast cell populations.
CRISPR Screening
Genome-wide CRISPR knockout screens can identify genes that positively or negatively regulate mast cell proliferation. This approach is powerful for discovering novel regulators and potential drug targets.
Western Blot and Immunohistochemistry
Western blotting and immunohistochemistry are used to detect expression of proliferation-related proteins such as cyclins and signaling intermediates in mast cells. These methods validate findings from transcriptomic and genetic studies.
How CRISPR Can Be Used to Study GO:0070668 positive regulation of mast cell proliferation
Knockout
CRISPR knockout is used to delete candidate genes in mast cell lines or primary cells to determine their necessity for proliferation. For example, knocking out CHMP4C in pancreatic cancer cells altered necroptosis and may affect mast cell survival. Knockout of KIT or IL4R would be expected to reduce mast cell proliferation.
Point Mutation
Point mutation knock-in via CRISPR allows researchers to model specific amino acid changes in genes such as KIT that are associated with altered proliferation. This approach can reveal how single nucleotide variants affect mast cell signaling and growth.
Knock-in
Knock-in of reporter genes or tags (e.g., GFP) into endogenous loci enables tracking of mast cell proliferation in real time. This can be combined with lineage tracing to study mast cell dynamics in vivo.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression is used to increase expression of genes or microRNAs such as miR-490-5p to test their sufficiency in promoting mast cell proliferation. Overexpression of SCF or IL-4 in stromal cells can also drive mast cell expansion.
How EDITGENE Supports positive regulation of mast cell proliferation Research
Researchers studying positive regulation of mast cell proliferation-related genes often need to determine whether a candidate gene is causally involved in driving or restraining mast cell expansion. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such investigations, from gene knockout to precise point mutations and overexpression, ensuring rigorous and reproducible results.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of mast cell proliferation research.
Frequently Asked Questions About positive regulation of mast cell proliferation
What is GO:0070668?
GO:0070668 is the Gene Ontology term for positive regulation of mast cell proliferation, defined as any process that activates or increases the rate or extent of mast cell proliferation.
What genes are involved in positive regulation of mast cell proliferation?
Key genes include KIT, IL4, STAT6, MIR490, and CHMP4C, among others, as identified in studies of mast cell biology and disease.
How is mast cell proliferation regulated?
Mast cell proliferation is positively regulated by cytokines such as SCF and IL-4, which activate signaling pathways like JAK/STAT and PI3K/AKT, and by microRNAs such as miR-490-5p.
What diseases are associated with mast cell proliferation?
Diseases include asthma, irritable bowel syndrome, allergic inflammation, and certain cancers where mast cells can be pro- or anti-tumor.
What research methods are used to study mast cell proliferation?
Methods include flow cytometry, single-cell RNA-seq, CRISPR screens, Western blot, and immunohistochemistry.
How can CRISPR be used to study mast cell proliferation?
CRISPR knockout, knock-in, point mutation, and overexpression models allow researchers to test the causal role of specific genes in mast cell proliferation.
What is the role of miR-490-5p in mast cell proliferation?
miR-490-5p is implicated in mast cell regulation in irritable bowel syndrome and may influence proliferation.
Can mast cells promote cancer?
Mast cells can have both pro-tumor and anti-tumor roles depending on the cancer type and microenvironment, as seen in esophageal squamous cell carcinoma and melanoma.
What is the role of stem cell factor in mast cell proliferation?
Stem cell factor (SCF) binds to KIT and is a major positive regulator of mast cell proliferation and survival.
How does ketotifen affect mast cell proliferation?
Ketotifen fumarate modulated the gingival microenvironment in feline gingivitis, potentially affecting mast cell proliferation.
Conclusion
Positive regulation of mast cell proliferation (GO:0070668) is a critical biological process that governs mast cell expansion in health and disease. Key regulators such as SCF, IL-4, and miR-490-5p provide mechanistic insights, while CRISPR-based models offer powerful tools to dissect causality. Understanding this process has therapeutic implications for asthma, irritable bowel syndrome, and cancer, where mast cells play diverse roles.
References
- 1. Yu L et al.. 2025. CHMP4C promotes pancreatic cancer progression by inhibiting necroptosis via the RIPK1/RIPK3/MLKL pathway.. J Adv Res 77:653-668 PMID: 39870301
- 2. Huang Y et al.. 2026. Single cell transcriptomics analyses reveal functional heterogeneity and anti-tumor role of mast cells in esophageal squamous cell carcinoma.. Front Immunol 17:1761865 PMID: 42597485
- 3. Chen Z et al.. 2003. Identification of novel IL-4/Stat6-regulated genes in T lymphocytes.. J Immunol 171(7):3627-35 PMID: 14500660
- 4. Ren HX et al.. 2017. Role of mast cell-miR-490-5p in irritable bowel syndrome.. World J Gastroenterol 23(1):93-102 PMID: 28104984
- 5. Lorentz A et al.. 2001. Regulation of human intestinal mast cells by stem cell factor and IL-4.. Immunol Rev 179:57-60 PMID: 11292028
- 6. Yuan W et al.. 2018. Ketotifen fumarate attenuates feline gingivitis related with gingival microenvironment modulation.. Int Immunopharmacol 65:159-173 PMID: 30316074
- 7. Grujic M et al.. 2020. Protective role of mouse mast cell tryptase Mcpt6 in melanoma.. Pigment Cell Melanoma Res 33(4):579-590 PMID: 31894627
- 8. Bradding P. 2003. The role of the mast cell in asthma: a reassessment.. Curr Opin Allergy Clin Immunol 3(1):45-50 PMID: 12582314
